Exchange Traded Concepts »

Crispr Therapeutics shares owned by Exchange Traded Concepts

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Exchange Traded Concepts from 13F filings

Historical chart of Exchange Traded Concepts investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Exchange Traded Concepts

Quarter filed Position value Share count Share price at filing
2024-03-31 $817k 12k 68.16
2023-03-31 $1.0M 22k 45.23
2021-03-31 $42k 342 122.81
2020-12-31 $46k 303 151.82
2020-09-30 $467k 5.6k 83.57
2020-06-30 $302k 4.1k 73.46
2020-03-31 $91k 2.1k 42.37
2019-12-31 $54k 894 60.40